SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea · Delayed Price · Currency is KRW 1,225.00
+22.00 (1.83%)
Nov 2, 2026, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 115.3 billion as of November 2, 2026. It is the 26,061st most valuable company in the world and the 1,144th biggest in South Korea. Its market cap has decreased by 20.09% in one year.
Market Cap
115.30B
Enterprise Value
n/a
Revenue
44.29B
Global Rank
Country Rank
#1,144 South Korea
PE Ratio
9.07
ChartMarket Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 115.30B, an increase of 544.67%. That is a compound annual growth rate of 6.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 115.30B | -19.93% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ilsung Is | 147.39B |
| Daihan Pharmaceutical | 145.53B |
| Hana Pharm | 143.43B |
| AptaBio Therapeutics | 143.00B |
| Dongwha Pharm.Co.,Ltd | 141.36B |
| Jeil Pharmaceutical Co.,Ltd | 126.46B |
| Ilyang Pharmaceutical Co.,Ltd | 124.76B |
| Kyongbo Pharmaceutical | 122.88B |